Literature DB >> 33128389

Evaluation of transport media for laboratory detection of SARS-CoV-2 in upper respiratory tract swab specimens.

Yvonne Penrod1, Denise Garcia1, S Terence Dunn1.   

Abstract

The reduced availability of commercial swabs and transport media for testing and administrative demands for increased testing capacity during the coronavirus disease 2019 (COVID-19) public health emergency has seriously challenged national laboratory testing programs, forcing many to use nontraditional collection devices, often without typical analytical assessment of their suitability in testing. Five common transport media (four commercial and one in-house) were evaluated for their suitability in the collection of nasopharyngeal swab specimens for subsequent molecular detection of severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2). Results suggest that these transport media provide dependable temporal stability of the SARS-CoV-2 virus without significant analytical interference of molecular assays. These findings are not only important for addressing critical laboratory supply chain shortages of transport media in the current COVID-19 health crisis but also for future pandemic planning, when again supplies of commercially available transport media might be depleted.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  2019 novel coronavirus; SARS-CoV-2; coronavirus; molecular detection; transport media

Mesh:

Substances:

Year:  2021        PMID: 33128389     DOI: 10.1002/jmv.26643

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  2 in total

1.  Identification of SARS-CoV-2 in post-mortem nasopharyngeal swabs.

Authors:  Pathum Sookaromdee; Viroj Wiwanitkit
Journal:  Forensic Sci Int       Date:  2021-05-11       Impact factor: 2.395

2.  Analysis by real-time PCR of five transport and conservation mediums of nasopharyngeal swab samples to COVID-19 diagnosis in Santiago of Chile.

Authors:  Carlos Barrera-Avalos; Roberto Luraschi; Eva Vallejos-Vidal; Maximiliano Figueroa; Esteban Arenillas; Daniela Barría; Felipe Hernández; Carlos Mateluna; Javier Mena; Claudia Rioseco; Claudia Torrent; Claudio Vergara; Gaby Gutiérrez; Javiera Quiroz; Javiera Alarcón; Julio Cartagena; Javiera Cayunao; Andrea Mella-Torres; Álvaro Santibañez; Sebastián Tapia; Alejandro Undurraga; Deborah Vargas; Valentina Wong; Ailen Inostroza-Molina; Daniel Valdés; Mónica Imarai; Claudio Acuña-Castillo; Felipe E Reyes-López; Ana M Sandino
Journal:  J Med Virol       Date:  2021-11-15       Impact factor: 20.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.